On this page
SLC30A9
solute carrier family 30 member 9
SLC30A9 is located on the short (p) arm of chromosome 4, at band 4p13. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 4 in the library →Available at Jeen Health
Clinical tests that include this
Overview
SLC30A9 is a member of the solute carrier family 30, which comprises proteins responsible for transporting zinc ions out of the cytoplasm into intracellular compartments or across the plasma membrane. The gene is located on chromosome 4 and encodes a transmembrane protein that participates in zinc homeostasis.
Zinc transporters are essential for maintaining appropriate zinc concentrations in different cellular locations, as zinc serves as a cofactor for hundreds of enzymes and plays structural roles in many proteins. The SLC30A9 protein contributes to this regulatory network, though its specific tissue distribution and physiological contexts remain areas of active research. Understanding the function of individual zinc transporters helps clarify how cells manage this critical micronutrient.
What the gene does
The SLC30A9 protein functions as a zinc efflux transporter, moving zinc ions from the cytoplasm into intracellular organelles or out of the cell. Members of the SLC30 family typically possess six transmembrane domains that form a channel through which zinc can pass, driven by concentration gradients and cellular energy states.
Zinc transport is crucial for numerous cellular processes. Proper zinc distribution supports the activity of zinc-dependent enzymes involved in DNA synthesis, protein folding, and antioxidant defence. The protein also influences cellular signalling pathways that depend on transient changes in zinc availability. By controlling zinc flux, SLC30A9 helps prevent both zinc deficiency and excess in specific cellular compartments, either of which can impair normal cell function.
The precise tissues and cell types where SLC30A9 operates most prominently, as well as its preferred subcellular localisations, continue to be characterised through ongoing research into the broader zinc transporter family.
Video: Genetics 101
Chromosome location
SLC30A9 is located on the short arm of chromosome 4 at position p13 (4p13). This chromosomal region contains numerous genes, and the specific cytogenetic band provides a reference point for genomic mapping and variant identification.
Structural details such as exon count and transcript variants have not been extensively documented in publicly available databases for this gene. Genomic coordinates can be referenced through genome browsers for precise nucleotide-level mapping.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein. As a member of the solute carrier family 30, the SLC30A9 protein is predicted to contain multiple transmembrane segments typical of zinc transporter proteins, which enable the protein to span cellular membranes and form a pathway for zinc ion movement. The structural organisation likely resembles other SLC30 family members, but specific domain boundaries and functional motifs await further experimental annotation.
Key variants
Genetic variants in SLC30A9 have been identified through sequencing studies, though the clinical significance of most variants remains uncertain. The gene is not currently included in routine diagnostic panels, reflecting the early stage of understanding regarding genotype-phenotype relationships for this transporter.
As research into zinc homeostasis advances, additional variants may be classified, and their effects on protein function may become clearer. Variants that alter zinc transport capacity could theoretically influence cellular processes dependent on proper zinc distribution.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
No specific inherited conditions have been definitively linked to pathogenic variants in SLC30A9 in current clinical databases. The gene's role in zinc transport suggests that severe loss-of-function variants could potentially affect cellular zinc homeostasis, but such associations have not been established in published medical literature.
The absence of known disease associations does not imply the gene is unimportant; rather, it may indicate that disruptions are either rare, have subtle effects, or are compensated by other zinc transporters. Further research into families with unexplained zinc metabolism disorders may reveal SLC30A9-related phenotypes in the future.
No disease links recorded for this gene in our reference set.
UK clinical status
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the SLC30A9 gene do?
SLC30A9 encodes a zinc transporter protein that moves zinc ions across cellular membranes, helping to maintain proper zinc levels in different parts of the cell. This contributes to normal enzyme function and cellular signalling processes that depend on zinc.
Are there any diseases associated with SLC30A9 variants?
Currently, no specific inherited conditions have been definitively linked to pathogenic variants in SLC30A9. The gene is not included in routine clinical diagnostic panels, and research into potential disease associations is ongoing.
Where is the SLC30A9 gene located?
SLC30A9 is located on chromosome 4 at position p13 (the short arm of chromosome 4). This genomic location can be referenced for identifying and characterising genetic variants in the gene.